The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus.

Annu Rev Microbiol

Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, United Kingdom.

Published: January 2003


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The emergence of Staphylococcus aureus resistant to vancomycin has caused considerable concern. Such strains are currently rare, although they have been isolated from many areas of the world. Considerable controversy surrounds strains of S. aureus displaying heterogeneous resistance to vancomycin regarding their definition and methods for detection. This has led to considerable variance in estimates of prevalence (0-1.3%-20% in Japan) and has hindered efforts to define the clinical relevance of these strains. The mechanism of resistance involves a complex reorganization of cell wall metabolism, leading to a grossly thickened cell wall with reduced peptidoglycan cross-linking. There may be many different ways in which strains achieve this endpoint. Current knowledge and theories are summarized.

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev.micro.56.012302.160806DOI Listing

Publication Analysis

Top Keywords

staphylococcus aureus
8
cell wall
8
prevalence mechanisms
4
mechanisms vancomycin
4
vancomycin resistance
4
resistance staphylococcus
4
aureus emergence
4
emergence staphylococcus
4
aureus resistant
4
resistant vancomycin
4

Similar Publications

Boron toxicity and salinity are major abiotic stress factors that cause significant yield losses, particularly in arid and semi-arid regions. Hyperaccumulator plants, such as Puccinella distans (Jacq.) Parl.

View Article and Find Full Text PDF

Background: To estimate the prevalence of biofilms in chronic wounds.

Methods: The authors performed a systematic review of prevalence studies and meta-analysis, structured according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. Articles were searched in Scopus (Elsevier), Web of Science (Clarivate), MEDLINE/PubMed (National Institutes of Health), and Embase (Elsevier) databases.

View Article and Find Full Text PDF

The complex interplay between circulating metabolites and immune responses, which is pivotal to disease pathophysiology, remains poorly understood and understudied in systematic research. Here, we performed a comprehensive analysis of the immune response and circulating metabolome in two Western European cohorts (534 and 324 healthy individuals) and one from sub-Saharan Africa (323 healthy donors). At the metabolic level, our analysis revealed sex-specific differences in the correlation between phosphatidylcholine and cytokine responses following ex vivo stimulation.

View Article and Find Full Text PDF

Orthopedic complications of sickle-cell disease in children.

Orthop Traumatol Surg Res

September 2025

Service de Chirurgie Orthopédique Pédiatrique, Hôpital Universitaire Robert-Debré, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, 48 Boulevard Sérurier, 75019 Paris, France.

Sickle cell disease is the most common serious genetic disease in the world. It is a systemic disease, characterized by vaso-occlusive phenomena, especially in the bone capillary network. Orthopedic complications are thus the most common, with a strong impact on quality of life.

View Article and Find Full Text PDF

Therapeutic Efficacy and Drug Metabolism of Griseorhodin A Induced by a Co-culture of Actinomycete Strain TMPU-20A002 and Mycobacterium smegmatis in Silkworm Infection Models.

Chem Pharm Bull (Tokyo)

September 2025

Division of Natural Product Chemistry, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.

In screening for antibacterial agents from co-cultures of Mycobacterium smegmatis and microbial resources, such as actinomycetes and fungi, the known hydroxyquinone antibiotic griseorhodin A (1) was isolated from a co-culture of actinomycete strain TMPU-20A002 and M. smegmatis. Compound 1 exhibited antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE), with minimum inhibitory concentrations of 0.

View Article and Find Full Text PDF